Colgate-Palmolive
CL · NYSE
About CL
- Employees
- 33,600
- Headquarters
- New York City, New York
- Listed
- Mar 31, 1930
- Sector
- Consumer Staples
- Industry
- Household Products
- Website
- colgatepalmolive.com
CL key statistics
- Market cap
- 74.45B
- Price-earnings ratio
- 36.91
- Dividend yield
- 2.45%
- Average volume
- 5.11M
- Volume
- 2.68M
- Open price
- $93.50
- High today
- $94.56
- Low today
- $93.21
- 52 Week high
- $99.33
- 52 Week low
- $74.55
Colgate-Palmolive (CL) at a glance
Colgate-Palmolive (CL) last traded at $94.54, with a market cap of 74.45B, a price-to-earnings ratio of 36.91 and a dividend yield of 2.45%.
Today the stock has traded between $93.21 and $94.56. The current price is 1.4% above the day's low and 0.0% below its high.
Volume so far is 2.68M shares, below the average of 5.11M shares a day.
Over the past year Colgate-Palmolive has ranged from $74.55 to $99.33, and now sits 81% of the way up that range.
Colgate-Palmolive met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $0.99 per share against an estimate of $0.9753.
The average analyst price target is $99.23, 5.0% above the current price, from 17 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy64.7%
- Hold35.3%
- Sell0.0%
- Low
- $75.75
- Now
- $94.54
- High
- $115.50
CL earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 8 quarters, by 1.9% on average.
- Q3 FY24: reported $0.91 per share against an estimate of $0.9117
- Q4 FY24: reported $0.91 per share against an estimate of $0.918
- Q1 FY25: reported $0.91 per share against an estimate of $0.884
- Q2 FY25: reported $0.92 per share against an estimate of $0.923
- Q3 FY25: reported $0.91 per share against an estimate of $0.915
- Q4 FY25: reported $0.95 per share against an estimate of $0.9395
- Q1 FY26: reported $0.97 per share against an estimate of $0.9734
- Q2 FY26: reported $0.99 per share against an estimate of $0.9753
CL news
- Press releaseBusiness Wire
- Press releasePRNewswire
Tom's of Maine Introduces Hydroxyapatite Toothpaste to Meet Rising Consumer Demand
- Press releaseBusiness Wire
Colgate-Palmolive Declares Regular Quarterly Dividend
- Press releasePRNewswire
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
- Press releaseBusiness Wire
Colgate-Palmolive Webcasts Fireside Chat at the Barclays 2026 Global Consumer Staples Conference
- Akanksha Bakshi
Colgate Warns New Tariffs Will Outweigh Recent Refund Windfall
- Press releaseBusiness Wire
Colgate Announces 2nd Quarter 2026 Results
- Press releaseBusiness Wire
Colgate-Palmolive Webcasts 2026 Second Quarter Earnings Conference Call July 31, 2026 – 8:30 a.m. ET
Similar companies
Companies in the same industry as Colgate-Palmolive
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- FRTTFort Technology$0.7121+32.63%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.